FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy
Related Topics >> FDA | Drug Trials | FDA approval | depression

Northstar brain therapy fails late-stage trial

Northstar Neuroscience says that a brain stimulation therapy intended to improve hand and arm function in stroke victims flunked a late-stage trial. Northstar's treatment uses electrical stimulation to the brain, but it failed to improve limb function by 20 percent, the primary goal of the trial. Seattle-based Northstar says it is unlikely that the data warrants FDA approval for that, but adds that it still has potential for other conditions, including depression and tinnitus.

- see this release
- check out the AFX report

More stories about depression   FDA   Drug Trials   FDA approval  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 7 + 22?
To combat spam, please solve the math question above.